Investor Overview Press Releases June 6, 2024 Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference May 7, 2024 Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update April 30, 2024 Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update View all » Events Jun 11, 202411:20 AM EDT Goldman Sachs Global Healthcare Conference May 7, 20245:00 PM EDT Aclaris Therapeutics First Quarter 2024 Conference Call Nov 13, 20238:00 AM EST Aclaris Therapeutics Call to Discuss Zunsemetinib Phase 2b Rheumatoid Arthritis Trial Results View all » Feature Presentation ITK Portfolio
June 6, 2024 Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 7, 2024 Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
April 30, 2024 Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update
Nov 13, 20238:00 AM EST Aclaris Therapeutics Call to Discuss Zunsemetinib Phase 2b Rheumatoid Arthritis Trial Results